Physiology and pathophysiology of GIP: A review (Q37040026)

17 August 2017

1 reference

title

Physiology and pathophysiology of GIP: a review (English)

1 reference

17 August 2017

Physiology and pathophysiology of GIP: A review (English)

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

30 November 2022

1 reference

T. Krarup

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810017

30 November 2022

P. H. Groop

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810017

30 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1810017

30 November 2022

publication date

1 November 1991

1 reference

full work available at URL

17 August 2017

9

1 reference

based on heuristic

inferred from page(s)

http://www.tandfonline.com/doi/pdf/10.1080/00365519109104567

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Scandinavian Journal of Clinical and Laboratory Investigation

30 November 2022

published in

1 reference

17 August 2017

51

1 reference

17 August 2017

7

1 reference

17 August 2017

571-579

1 reference

On the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane

17 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Immunoassay of endogenous plasma insulin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

A Gastric Inhibitory Polypeptide II: The Complete Amino Acid Sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Immunoreactive gastric inhibitory polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

The isolation and sequencing of human gastric inhibitory peptide (GIP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Gastric inhibitory polypeptide: a gut hormone with anabolic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Effect of cephalic-vagal stimulation on insulin, gastric inhibitory polypeptide, and pancreatic polypeptide release in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Kinetics of human C-peptide in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Relationship between changes in GIP concentrations and changes in insulin and C-peptide concentrations after guar gum therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

The hepatic extraction of gastric inhibitory polypeptide and insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

The influence of body weight, age and glucose tolerance on the relationship between GIP secretion and beta-cell function in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Discrepancy Between Plasma C-Peptide and Insulin Response to Oral and Intravenous Glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Diminished Immunoreactive Gastric Inhibitory Polypeptide Response to a Meal in Newly Diagnosed Type I (Insulin-Dependent) Diabetics*

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and Type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365519109104567

Bulletin de l'Academie royale de medecine de Belgique

21 January 2018

2

12

620

La Barre J

1932

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION

30 November 2022

4

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE

30 November 2022

5

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Stimulation of insulin secretion by gastric inhibitory polypeptide in man

30 November 2022

7

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

American Journal of Physiology

30 November 2022

13

249

E195

Krarup T

1985

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Heterogeneity of immunoreactive gastric inhibitory polypeptide in the plasma of newly diagnosed type 1 (insulin-dependent) diabetics.

30 November 2022

15

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP)

30 November 2022

19

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

What are 'physiological' plasma GIP levels in man after intravenous infusion of porcine GIP?

30 November 2022

21

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Diurnal variation of plasma gastric inhibitory polypeptide in man

30 November 2022

23

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

The enteral insulin-stimulation after pancreas transplantation in the pig

30 November 2022

29

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Studies of the entero-insular axis following pancreas transplantation in man: neural or hormonal control?

30 November 2022

30

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

30 November 2022

32

33

486

Polonsky K S

1984

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Incretin effect due to increased secretion and decreased clearance of insulin in normal humans

30 November 2022

34

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses

30 November 2022

35

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Effects of acarbose on the relationship between changes in GIP and insulin responses to meals in normal subjects

30 November 2022

37

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Gastric inhibitory polypeptide in newly diagnosed ketotic type I (insulin-dependent) diabetics.

30 November 2022

43

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Gastric Inhibitory Polypeptide in Obesity and Diabetes Mellitus*

30 November 2022

44

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatment

30 November 2022

45

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitus.

30 November 2022

48

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Effect of serial test meals on plasma immunoreactive GIP in non-insulin dependent diabetic patients and non-diabetic controls

30 November 2022

54

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

30 November 2022

56

1 reference

https://api.crossref.org/works/10.1080/00365519109104567

30 November 2022

Identifiers

1 reference

17 August 2017

1 reference